European Association of Hospital Pharmacists

Synergy Satellites Topics - 2023:

1. Antibiotic Stewardship - What should it mean for the different players in health systems?
2. Patient blood management - a multimodal approach
3. Gene and cell therapy - new challenges for hospital pharmacists
4. Spotlight on rare diseases in children
5. TDM for biologicals - as close as we can get
6. Strategies to optimise antithrombotic therapy in cancer patients
7. Traceability of medical devices, is Europe ready?
8. Automated compounding: opportunity with a challenge
9. Biosimilars interchangeability - are we ready to close the debate?
10. A-Z of reversal agents for anticoagulants
11. Site agnosticism in cancer therapy - one drug fits all?
12. Smart medical devices, from adherence to bionics
13. The value of biosimilars - budget constraints, patient and prescriber perspectives
14. The infectious disease (ID) - pharmacist - diagnostics and therapy
15. Closed System Transfer Devices - new perspectives?
16. Preparation of antineoplastic drugs - hands or robots?
17. Multiple Sclerosis - conventional treatment versus autologous hematopoietic stem cell transplantation
18. Homecare - delivering hospital pharmacy at home
19. New options for managing haemophilia - reclaiming one’s life!
20. New biosimilars outside oncology
21. How to create uptake of biosimilars
22. Lung cancer - targeted therapies for known oncogene mutations
23. Asthma, new devices
24. Implants, medical devices, health technology assessment
25. 3D medicines printing - adding an extra dimension to personalized pharmacotherapy
26. Non Biologic Complex Drugs - SOLD
27. COVID-19 vaccination in cancer patients
28. Renal Cell Cancer in the Era of COVID-19
29. Long-acting HIV treatment options - the game-changer for perfect adherence?
30. Treatment options for COVID-19: where do we stand?

EAHP SYNERGY MASTERCLASSES are also available. For more information please click here.